Disc Medicine (IRON) Accumulated Expenses (2020 - 2026)
Disc Medicine's (IRON) quarterly Accumulated Expenses came in at $6.8 million in Q1 2026, up 276.56% year-on-year from $1.8 million in Q1 2025, and down 56.13% on a QoQ basis from $15.6 million in Q4 2025.
Disc Medicine (IRON) Accumulated Expenses (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Accumulated Expenses data on file, last reported at $6.8 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses rose 276.56% year-over-year to $6.8 million in Q1 2026; TTM through Mar 2026 was $6.8 million, a 276.56% increase from a year earlier, with the FY2025 full-year figure at $15.6 million, up 92.18% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $6.8 million, down from $15.6 million in the prior quarter.
- Over the last five years, Accumulated Expenses for IRON reached as high as $15.6 million in Q4 2025 and fell as low as $325000.0 in Q3 2022.
- Historically, Accumulated Expenses has averaged $5.2 million across 5 years, with a median of $5.5 million in 2024.
- Across the five-year window, Accumulated Expenses plunged 95.17% in 2022 and surged 1612.92% in 2023, its largest moves.
- Year by year, Accumulated Expenses stood at $6.1 million in 2022, then advanced by 0.82% to $6.2 million in 2023, then jumped by 31.47% to $8.1 million in 2024, then jumped by 92.18% to $15.6 million in 2025, then plunged by 56.13% to $6.8 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $6.8 million in Q1 2026, $15.6 million in Q4 2025, and $9.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Disc Medicine | 2.90 Bn | 2.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.83 Mn |
| Dec 31, 2025 | 15.56 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 6.16 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 8.10 Mn |
| Sep 30, 2024 | 5.51 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 6.16 Mn |
| Sep 30, 2023 | 5.57 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 4.03 Mn |
| Dec 31, 2022 | 6.11 Mn |
| Sep 30, 2022 | 325,000.00 |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 4.10 Mn |
| Sep 30, 2021 | 6.72 Mn |
| Jun 30, 2021 | 5.01 Mn |